Clinical Trial Update: Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the reproducibility of 18F uptake in solid tumors using PET imaging after intravenous administration of a fluorine-18 tracer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Glioblastoma
• Head and Neck Cancer
• Lung Cancer
• Renal Cell Carcinoma
• Sarcoma
• Solid Tumors

Drugs mentioned

• Fluorine-18 PET radiotracer (fluorine-18 labeled PET imaging tracer)

Snippet

Sponsor: GE Healthcare | Conditions: Solid Tumors, High Grade Gliomas | Phase 2 | Status: COMPLETED | Results posted: 2014-06-09